Search for: [Abstract = "imilarities to the etiology ofCAD in inflammatory and calcific processes. Therefore, in almost halfof the patients aged ≥70 years, newly diagnosed AS coexists withCAD. The ESC guidelines recommend to perform coronaryangiography before valvular heart surgery in case of any of thefollowing\: history of CAD, suspected myocardial ischaemia, leftventricular systolic dysfunction, in men >40 years andpostmenopausal women, or in patients with ≥1 cardiovascular riskfactor \(Class I, Level C\). In patients with a primary indication foraortic valve surgery, coronary artery bypass grafting \(CABG\) remains the preferred treatment of CAD if coronary artery diameter stenosis is≥70% \(Class I, Level C\). Therefore, until recently, the standardtreatment option for patients with severe AS and concomitant CAD was AVR combined with CABG. After the introduction of TAVI, newcomplex models of treatment have been developed with the additionaluse of percutaneous coronary intervention \(PCI\) together with BAV.Nowadays patients with significant CAD scheduled for BAV\/TAVIcan be treated with PCI at the time of BAV\/TAVI \(as a singleprocedure\) or with staged PCI. The post\-implantation paravalvularleak \(PVL\) remains an important TAVI\-related complication worsening clinical outcomes. PVL is present in up to 70% of all patients undergoing TAVI, and more than mild PVL has been reported in approximately 10–15% patients."]

Number of results: 1